These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 24525088

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Correlation between imaging and molecular classification of breast cancers.
    Boisserie-Lacroix M, Hurtevent-Labrot G, Ferron S, Lippa N, Bonnefoi H, Mac Grogan G.
    Diagn Interv Imaging; 2013 Nov; 94(11):1069-80. PubMed ID: 23867597
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Triple-negative breast cancer: correlation between MR imaging and pathologic findings.
    Uematsu T, Kasami M, Yuen S.
    Radiology; 2009 Mar; 250(3):638-47. PubMed ID: 19244039
    [Abstract] [Full Text] [Related]

  • 6. Can breast cancer molecular subtype help to select patients for preoperative MR imaging?
    Grimm LJ, Johnson KS, Marcom PK, Baker JA, Soo MS.
    Radiology; 2015 Feb; 274(2):352-8. PubMed ID: 25325325
    [Abstract] [Full Text] [Related]

  • 7. Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment.
    Bufi E, Belli P, Di Matteo M, Terribile D, Franceschini G, Nardone L, Petrone G, Bonomo L.
    Eur J Radiol; 2014 Sep; 83(9):1631-8. PubMed ID: 24938669
    [Abstract] [Full Text] [Related]

  • 8. Beyond triple-negative breast cancer: the need to define new subtypes.
    Constantinidou A, Jones RL, Reis-Filho JS.
    Expert Rev Anticancer Ther; 2010 Aug; 10(8):1197-213. PubMed ID: 20735307
    [Abstract] [Full Text] [Related]

  • 9. Molecular stratification of triple-negative breast cancers.
    Perou CM.
    Oncologist; 2010 Aug; 15 Suppl 5():39-48. PubMed ID: 21138954
    [Abstract] [Full Text] [Related]

  • 10. MR imaging features of triple-negative breast cancers.
    Sung JS, Jochelson MS, Brennan S, Joo S, Wen YH, Moskowitz C, Zheng J, Dershaw DD, Morris EA.
    Breast J; 2013 Aug; 19(6):643-9. PubMed ID: 24015869
    [Abstract] [Full Text] [Related]

  • 11. Molecular insights on basal-like breast cancer.
    Valentin MD, da Silva SD, Privat M, Alaoui-Jamali M, Bignon YJ.
    Breast Cancer Res Treat; 2012 Jul; 134(1):21-30. PubMed ID: 22234518
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MR imaging of triple-negative breast cancer.
    Uematsu T.
    Breast Cancer; 2011 Jul; 18(3):161-4. PubMed ID: 21181317
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Breast cancer molecular subtype as a predictor of the utility of preoperative MRI.
    Ha R, Jin B, Mango V, Friedlander L, Miloshev V, Malak S, Wynn R.
    AJR Am J Roentgenol; 2015 Jun; 204(6):1354-60. PubMed ID: 26001248
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Magnetic resonance imaging of breast cancer and correlation with prognostic factors.
    Chang YW, Kwon KH, Choi DL, Lee DW, Lee MH, Lee HK, Yang SB, Kim Y, Seo DY.
    Acta Radiol; 2009 Nov; 50(9):990-8. PubMed ID: 19863408
    [Abstract] [Full Text] [Related]

  • 20. Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation.
    Karn T, Pusztai L, Ruckhäberle E, Liedtke C, Müller V, Schmidt M, Metzler D, Wang J, Coombes KR, Gätje R, Hanker L, Solbach C, Ahr A, Holtrich U, Rody A, Kaufmann M.
    Eur J Cancer; 2012 Jan; 48(1):12-23. PubMed ID: 21741824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.